Bausch Health Companies (BHC) Gross Profit (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Gross Profit came in at $2.1 billion in Q2 2026, up 17.79% year-over-year from $1.8 billion in Q2 2025, and up 16.42% quarter-over-quarter from $1.8 billion in Q1 2026.
Analysis
Bausch Health Companies (BHC) Gross Profit (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Gross Profit across 18 years of filings, most recently posting $2.1 billion for Q2 2026.
- In Q2 2026, Gross Profit rose 17.79% year-over-year to $2.1 billion; the TTM figure through Jun 2026 stood at $7.9 billion (up 11.76% YoY), while the FY2025 annual figure was $7.3 billion, up 6.1% from the prior year.
- Gross Profit came in at $2.1 billion for Q2 2026 at Bausch Health Companies, up from $1.8 billion in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $2.1 billion in Q2 2026 to a low of $1.4 billion in Q1 2023.
- Average Gross Profit over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2023.
- Year-over-year, Gross Profit declined 6.48% in 2022 and advanced 17.79% in 2026.
- Over 5 years, Gross Profit stood at $1.6 billion in 2022, then rose by 10.23% to $1.7 billion in 2023, then increased by 7.88% to $1.8 billion in 2024, then gained by 8.93% to $2.0 billion in 2025, then rose by 4.27% to $2.1 billion in 2026.
- Per Business Quant data, the three most recent Gross Profit figures were $2.1 billion in Q2 2026, $1.8 billion in Q1 2026, and $2.0 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.10 Bn |
| Mar 31, 2026 | 1.80 Bn |
| Dec 31, 2025 | 2.01 Bn |
| Sep 30, 2025 | 1.95 Bn |
| Jun 30, 2025 | 1.78 Bn |
| Mar 31, 2025 | 1.58 Bn |
| Dec 31, 2024 | 1.85 Bn |
| Sep 30, 2024 | 1.83 Bn |
| Jun 30, 2024 | 1.70 Bn |
| Mar 31, 2024 | 1.53 Bn |
| Dec 31, 2023 | 1.71 Bn |
| Sep 30, 2023 | 1.63 Bn |
| Jun 30, 2023 | 1.53 Bn |
| Mar 31, 2023 | 1.37 Bn |
| Dec 31, 2022 | 1.55 Bn |
| Sep 30, 2022 | 1.47 Bn |
| Jun 30, 2022 | 1.40 Bn |
| Mar 31, 2022 | 1.38 Bn |
| Dec 31, 2021 | 1.59 Bn |
| Sep 30, 2021 | 1.54 Bn |